Drs. Ajay Kuriyan, Shriji Patel and Basil Williams join to discuss the September 2020 edition of Retinal Physician, including a discussion of teleophthalmology for diabetic retinopathy, new pathways to treat diabetic macular edema, and sickle cell retinopathy management. They also spend some time sharing thoughts on the NBA players' protest during the playoffs over social justice.
Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Dorc, Oxurion, and Regeneron. Dr. Kuriyan receives grant funding from Second Sight and Genentech/Roche and is a consultant for Alimera Sciences, Allergan, Bausch Health, Genentech/Roche, Novartis, Regeneron. Dr. Patel and Dr. Williams have no financial disclosures.
CME Information
Release: August 31, 2020; expires August 31, 2023
Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.